{"id":248194,"date":"2026-09-16T10:52:11","date_gmt":"2026-09-16T05:22:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=248194"},"modified":"2026-09-16T10:52:11","modified_gmt":"2026-09-16T05:22:11","slug":"himalaya-nutravedics-india-initial-public-offering-review","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/","title":{"rendered":"Himalaya Nutravedics India IPO Review: Key Details, Company Overview and Financials"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Himalaya Nutravedics India IPO opens 22 Sep, closes 24 Sep 2026. Price band not yet announced. Lists on BSE SME.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Himalaya Nutravedics India IPO is a bookbuilding SME issue of up to 25,00,000 equity shares, open for bidding from 22 to 24 September 2026. The Hyderabad based Ayurvedic and nutraceutical manufacturer is raising the entire issue as a fresh issue, with no offer for sale. Shares are proposed to list on BSE SME. As of this writing, the official price band and lot size had not yet been announced, though the company has reported FY26 revenue growth of 105 percent and profit growth of 231 percent.<\/p>\n<\/p><\/div>\n<p>The Himalaya Nutravedics India IPO is a bookbuilding issue consisting solely of a fresh issue of up to 25,00,000 equity shares, with no offer for sale component. The IPO will open for subscription on 22 September 2026 and close on 24 September 2026. The shares are proposed to list on the SME platform of BSE.<\/p>\n<p>As of the time of writing, the official price band, lot size and minimum investment amount for the Himalaya Nutravedics India IPO had not yet been announced. Investors should refer to the RHP or the company&#8217;s official announcements closer to the issue opening for these confirmed figures.<\/p>\n<p>Nirbhay Capital Services Pvt. Ltd. is the book-running lead manager for the Himalaya Nutravedics India IPO, while Kfin Technologies Ltd. is the registrar to the issue.<\/p>\n<p>For detailed information on the company&#8217;s business, financials, risk factors and the proposed utilisation of proceeds, investors should refer to the Himalaya Nutravedics India IPO Red Herring Prospectus (RHP) before making an investment decision.<\/p>\n<p style=\"margin-top:24px;\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Company_Overview\" title=\"Company Overview\">Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#IPO_Details\" title=\"IPO Details\">IPO Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Industry_Context\" title=\"Industry Context\">Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Business_Strengths\" title=\"Business Strengths\">Business Strengths<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Business_Risks\" title=\"Business Risks\">Business Risks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Financial_Performance\" title=\"Financial Performance\">Financial Performance<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Himalaya_Nutravedics_India_Ltd_%E2%80%93_Financials_Rs_in_Lakh\" title=\"Himalaya Nutravedics India Ltd. &#8211; Financials (Rs in Lakh)\">Himalaya Nutravedics India Ltd. &#8211; Financials (Rs in Lakh)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Key_Ratios_and_Metrics\" title=\"Key Ratios and Metrics\">Key Ratios and Metrics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Objects_of_the_Offer\" title=\"Objects of the Offer\">Objects of the Offer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#FAQs\" title=\"FAQs\">FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#What_are_the_Himalaya_Nutravedics_India_IPO_dates_and_when_will_it_list\" title=\"What are the Himalaya Nutravedics India IPO dates, and when will it list?\">What are the Himalaya Nutravedics India IPO dates, and when will it list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#What_is_the_price_band_for_the_Himalaya_Nutravedics_India_IPO\" title=\"What is the price band for the Himalaya Nutravedics India IPO?\">What is the price band for the Himalaya Nutravedics India IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#What_does_Himalaya_Nutravedics_India_Limited_actually_manufacture\" title=\"What does Himalaya Nutravedics India Limited actually manufacture?\">What does Himalaya Nutravedics India Limited actually manufacture?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Is_the_Himalaya_Nutravedics_India_IPO_a_fresh_issue_or_does_it_include_an_offer_for_sale\" title=\"Is the Himalaya Nutravedics India IPO a fresh issue or does it include an offer for sale?\">Is the Himalaya Nutravedics India IPO a fresh issue or does it include an offer for sale?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#How_has_Himalaya_Nutravedics_India_performed_financially_in_recent_years\" title=\"How has Himalaya Nutravedics India performed financially in recent years?\">How has Himalaya Nutravedics India performed financially in recent years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#What_are_the_key_strengths_highlighted_for_the_Himalaya_Nutravedics_India_IPO\" title=\"What are the key strengths highlighted for the Himalaya Nutravedics India IPO?\">What are the key strengths highlighted for the Himalaya Nutravedics India IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#What_are_the_main_risks_or_concerns_flagged_for_the_Himalaya_Nutravedics_India_IPO\" title=\"What are the main risks or concerns flagged for the Himalaya Nutravedics India IPO?\">What are the main risks or concerns flagged for the Himalaya Nutravedics India IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Who_are_the_lead_manager_and_registrar_for_the_Himalaya_Nutravedics_India_IPO\" title=\"Who are the lead manager and registrar for the Himalaya Nutravedics India IPO?\">Who are the lead manager and registrar for the Himalaya Nutravedics India IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/himalaya-nutravedics-india-initial-public-offering-review\/#Is_the_Himalaya_Nutravedics_India_IPO_a_good_investment\" title=\"Is the Himalaya Nutravedics India IPO a good investment?\">Is the Himalaya Nutravedics India IPO a good investment?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Company_Overview\"><\/span><strong>Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Incorporated in June 2022, Himalaya Nutravedics India Limited manufactures, markets and distributes Ayurvedic and nutraceutical formulations, and also undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies. The company&#8217;s portfolio includes classical (Shastric) Ayurvedic formulations based on traditional Ayurvedic texts, proprietary Ayurvedic formulations, and nutraceutical products across dosage forms including soft gelatin capsules, hard gelatin capsules, tablets, liquid orals, medicated oils and protein powders, targeting therapeutic categories such as digestive health, immunity, metabolic health and pain management.<\/p>\n<p>The company markets its branded products through healthcare practitioners and has expanded its presence across 17 states and one union territory in India, supported by a stockist-driven distribution network and an on-ground sales and marketing team of around 56 personnel, including regional managers and medical representatives. Its manufacturing facility is located in Hyderabad, Telangana, and holds ISO 22000:2018, ISO 9001:2015 and WHO-GMP certifications. As of 30 April 2026, the company had 80 employees.<\/p>\n<p><em>Read on for the complete Himalaya Nutravedics India IPO details, including price band, lot size, listing timeline and the company&#8217;s financial track record.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"IPO_Details\"><\/span><strong>IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"background:#1F4E79;color:#fff;text-align:left;\">Particulars<\/th>\n<th style=\"background:#1F4E79;color:#fff;text-align:left;\">Details<\/th>\n<\/tr>\n<tr>\n<td>IPO Date<\/td>\n<td>22 to 24 September 2026<\/td>\n<\/tr>\n<tr>\n<td>Face Value<\/td>\n<td>Rs 10 per share<\/td>\n<\/tr>\n<tr>\n<td>Price Band<\/td>\n<td>Not yet officially announced<\/td>\n<\/tr>\n<tr>\n<td>Lot Size<\/td>\n<td>Not yet officially announced<\/td>\n<\/tr>\n<tr>\n<td>Issue Type<\/td>\n<td>Bookbuilding IPO<\/td>\n<\/tr>\n<tr>\n<td>Sale Type<\/td>\n<td>Fresh Issue only (no OFS)<\/td>\n<\/tr>\n<tr>\n<td>Total Issue Size<\/td>\n<td>Up to 25,00,000 shares<\/td>\n<\/tr>\n<tr>\n<td>Fresh Issue<\/td>\n<td>Up to 25,00,000 shares<\/td>\n<\/tr>\n<tr>\n<td>Offer for Sale<\/td>\n<td>Nil<\/td>\n<\/tr>\n<tr>\n<td>Listing Exchange<\/td>\n<td>BSE SME<\/td>\n<\/tr>\n<\/table>\n<p><em>(Compiled from the RHP\/DRHP and market updates)<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Industry_Context\"><\/span><strong>Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Himalaya Nutravedics India IPO arrives against the backdrop of a growing Ayurvedic and nutraceutical industry in India. Here is the broader industry context relevant to the business.<\/p>\n<ul>\n<li>India&#8217;s Ayurvedic formulations and nutraceuticals industry sits within the broader pharmaceutical and wellness ecosystem, spanning classical Ayurvedic products, proprietary herbal formulations and dietary supplements, and has grown alongside rising consumer interest in natural and preventive healthcare.<\/li>\n<li>Contract manufacturing is a common growth avenue for Ayurvedic and nutraceutical companies, allowing them to utilise manufacturing capacity for other brands while building their own branded product lines in parallel.<\/li>\n<li>Distribution through healthcare practitioners and a stockist network, as Himalaya Nutravedics does, is a well-established go-to-market model in India&#8217;s Ayurvedic and nutraceutical sector, helping build credibility with end consumers.<\/li>\n<li>Quality certifications such as ISO 22000:2018, ISO 9001:2015 and WHO-GMP are important differentiators in this industry, supporting both domestic credibility and, potentially, future export opportunities.<\/li>\n<li>The sector remains fragmented, with numerous regional and national players, making brand building, geographic expansion and consistent quality important competitive factors for sustained growth.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Business_Strengths\"><\/span><strong>Business Strengths<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Here are the key strengths investors evaluating the Himalaya Nutravedics India IPO should weigh:<\/p>\n<ul>\n<li>A dual business model combining branded Ayurvedic and nutraceutical products with third-party contract manufacturing, providing revenue diversification.<\/li>\n<li>Sharp financial growth, with total income rising from Rs 14.43 crore in FY24 to Rs 43.12 crore in FY26, and profit after tax increasing from Rs 0.43 crore to Rs 7.39 crore over the same period.<\/li>\n<li>Multiple quality certifications, including ISO 22000:2018, ISO 9001:2015 and WHO-GMP, alongside a presence across 17 states and one union territory.<\/li>\n<li>Improving profitability, with EBITDA margin rising from around 6.5 percent in FY24 to close to 18.8 percent in FY26.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><strong>Screen pharmaceutical and nutraceutical sector stocks on the Univest Screener<\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Business_Risks\"><\/span><strong>Business Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alongside these strengths, the Himalaya Nutravedics India IPO also carries the following business risks:<\/p>\n<ul>\n<li>The official price band and lot size were not available at the time of writing, making an early assessment of the issue&#8217;s valuation difficult.<\/li>\n<li>Very rapid recent growth, with profit after tax up 231 percent in FY26, may not be sustainable at the same pace going forward, and full valuation ratios cannot be computed until the price band is announced.<\/li>\n<li>The Ayurvedic and nutraceutical industry is competitive and fragmented, and revenue concentration among a subset of states (Telangana, Andhra Pradesh, Kerala, Gujarat and Uttar Pradesh) creates some geographic dependence.<\/li>\n<li>As with any SME stock, Himalaya Nutravedics India shares may see limited post-listing liquidity and price volatility.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Financial_Performance\"><\/span><strong>Financial Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Himalaya Nutravedics India IPO comes after a period of very strong financial growth. The company&#8217;s total income increased by around 105 percent and profit after tax rose by around 231 percent between the year ended 31 March 2025 and 31 March 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Himalaya_Nutravedics_India_Ltd_%E2%80%93_Financials_Rs_in_Lakh\"><\/span><strong>Himalaya Nutravedics India Ltd. &#8211; Financials (Rs in Lakh)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"background:#1F4E79;color:#fff;text-align:left;\">Particulars<\/th>\n<th style=\"background:#1F4E79;color:#fff;text-align:left;\">Fiscal 2026<\/th>\n<th style=\"background:#1F4E79;color:#fff;text-align:left;\">Fiscal 2025<\/th>\n<th style=\"background:#1F4E79;color:#fff;text-align:left;\">Fiscal 2024<\/th>\n<\/tr>\n<tr>\n<td>Total Income<\/td>\n<td>4,312.00<\/td>\n<td>2,099.70<\/td>\n<td>1,442.90<\/td>\n<\/tr>\n<tr>\n<td>EBITDA<\/td>\n<td>810.30<\/td>\n<td>299.00<\/td>\n<td>93.50<\/td>\n<\/tr>\n<tr>\n<td>EBITDA Margin (%)<\/td>\n<td>18.79% (computed)<\/td>\n<td>14.24% (computed)<\/td>\n<td>6.48% (computed)<\/td>\n<\/tr>\n<tr>\n<td>Profit After Tax (PAT)<\/td>\n<td>739.00<\/td>\n<td>223.20<\/td>\n<td>42.60<\/td>\n<\/tr>\n<tr>\n<td>PAT Margin (%)<\/td>\n<td>17.14% (computed)<\/td>\n<td>10.63% (computed)<\/td>\n<td>2.95% (computed)<\/td>\n<\/tr>\n<\/table>\n<p><em>Amounts in Rs Lakh unless stated otherwise, compiled from published Himalaya Nutravedics India IPO financial disclosures. EBITDA margin and PAT margin figures are computed from disclosed absolute figures. Net worth and total borrowings were not separately available in the sources used for this review; investors should refer to the RHP for the complete restated financial statements.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Ratios_and_Metrics\"><\/span><strong>Key Ratios and Metrics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Detailed post-issue valuation ratios such as P\/E, ROE and ROCE for the Himalaya Nutravedics India IPO could not be computed at the time of writing, since the official price band has not yet been disclosed. Investors should check these figures once the RHP and price band are officially announced.<\/p>\n<p><em>These ratios offer a quick snapshot of how the Himalaya Nutravedics India IPO is priced relative to the company&#8217;s profitability and net worth.<\/em><\/p>\n<table border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"background:#1F4E79;color:#fff;text-align:left;\">KPI (Mar 31, 2026)<\/th>\n<th style=\"background:#1F4E79;color:#fff;text-align:left;\">Value<\/th>\n<\/tr>\n<tr>\n<td>EBITDA Margin (FY26)<\/td>\n<td>18.79%<\/td>\n<\/tr>\n<tr>\n<td>PAT Margin (FY26)<\/td>\n<td>17.14%<\/td>\n<\/tr>\n<tr>\n<td>Revenue Growth (FY25 to FY26)<\/td>\n<td>~105%<\/td>\n<\/tr>\n<tr>\n<td>PAT Growth (FY25 to FY26)<\/td>\n<td>~231%<\/td>\n<\/tr>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Objects_of_the_Offer\"><\/span><strong>Objects of the Offer<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>As the Himalaya Nutravedics India IPO is entirely a fresh issue, the company will receive the full net proceeds, though the detailed, itemised objects of the issue were not separately available in the sources used for this review.<\/p>\n<ul>\n<li>Funding working capital and business growth requirements<\/li>\n<li>General corporate purposes<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the Univest iOS App or Univest Android App to track the Himalaya Nutravedics India IPO and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><em>Here is the bottom line on the Himalaya Nutravedics India IPO.<\/em><\/p>\n<p>The Himalaya Nutravedics India IPO reflects a fast-growing Ayurvedic and nutraceutical manufacturer with a diversified branded-plus-contract-manufacturing model, multiple quality certifications, and improving profitability, entirely funded through a fresh issue.<\/p>\n<p>However, the official price band was not yet available at the time of writing, and the sustainability of very rapid recent growth, competitive industry dynamics, and typical SME liquidity risk are factors that could affect the investment case for the Himalaya Nutravedics India IPO.<\/p>\n<p>Overall, investors weighing the Himalaya Nutravedics India IPO should evaluate the company&#8217;s business model, financial performance, industry outlook, competitive positioning, valuation and risk factors in detail once the official price band is announced, and carefully review the Red Herring Prospectus (RHP) before making an informed investment decision.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<p>Univest does not publish grey market premium figures. Grey market premium is an unofficial and unregulated indicator collected informally outside the stock exchanges. It is not published, verified or endorsed by SEBI, NSE or BSE, can vary widely between trackers, and is not always accurate.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_Himalaya_Nutravedics_India_IPO_dates_and_when_will_it_list\"><\/span><strong>What are the Himalaya Nutravedics India IPO dates, and when will it list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Himalaya Nutravedics India IPO opens for subscription on 22 September 2026 and closes on 24 September 2026. The shares are proposed to list on the SME platform of BSE, with the exact listing date to be confirmed closer to the allotment finalisation, as it has not been officially announced at the time of writing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_price_band_for_the_Himalaya_Nutravedics_India_IPO\"><\/span><strong>What is the price band for the Himalaya Nutravedics India IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the time of writing, the official price band and lot size for the Himalaya Nutravedics India IPO had not yet been announced. Investors should check the company&#8217;s official announcements or the RHP closer to the issue opening date on 22 September 2026 for the confirmed price band and minimum investment amount.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Himalaya_Nutravedics_India_Limited_actually_manufacture\"><\/span><strong>What does Himalaya Nutravedics India Limited actually manufacture?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Himalaya Nutravedics India manufactures, markets and distributes Ayurvedic and nutraceutical formulations, including classical Shastric Ayurvedic formulations, proprietary Ayurvedic products and nutraceuticals across dosage forms such as soft gelatin capsules, tablets, liquid orals, medicated oils and protein powders. The company targets therapeutic categories including digestive health, immunity, metabolic health and pain management, and also undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_the_Himalaya_Nutravedics_India_IPO_a_fresh_issue_or_does_it_include_an_offer_for_sale\"><\/span><strong>Is the Himalaya Nutravedics India IPO a fresh issue or does it include an offer for sale?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Himalaya Nutravedics India IPO consists solely of a fresh issue of up to 25,00,000 equity shares, with no offer for sale component. This means, subject to issue expenses, all proceeds raised will flow into the company rather than providing an exit for existing shareholders.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Himalaya_Nutravedics_India_performed_financially_in_recent_years\"><\/span><strong>How has Himalaya Nutravedics India performed financially in recent years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Himalaya Nutravedics India&#8217;s total income grew from Rs 14.43 crore in FY24 to Rs 20.997 crore in FY25 and then to Rs 43.12 crore in FY26, a roughly 105 percent increase in the most recent year. Profit after tax showed an even sharper rise, from Rs 0.43 crore in FY24 to Rs 2.23 crore in FY25 and then to Rs 7.39 crore in FY26, a 231 percent jump, with EBITDA margin improving from around 6.5 percent in FY24 to close to 18.8 percent in FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_strengths_highlighted_for_the_Himalaya_Nutravedics_India_IPO\"><\/span><strong>What are the key strengths highlighted for the Himalaya Nutravedics India IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Himalaya Nutravedics India combines a branded Ayurvedic and nutraceutical products business with third-party contract manufacturing, providing revenue diversification across two related business lines. The company has delivered very strong recent growth, with profit after tax rising more than 17 times between FY24 and FY26, supported by multiple quality certifications, including ISO 22000:2018, ISO 9001:2015 and WHO-GMP, and a distribution presence across 17 states and one union territory.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_risks_or_concerns_flagged_for_the_Himalaya_Nutravedics_India_IPO\"><\/span><strong>What are the main risks or concerns flagged for the Himalaya Nutravedics India IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The most immediate practical concern is that the official price band and lot size were not available at the time of writing, making it difficult for prospective investors to assess valuation until this is confirmed. The company&#8217;s very rapid recent growth, with profit after tax up 231 percent in FY26, may not be sustainable at the same pace going forward, and the Ayurvedic and nutraceutical industry remains competitive and fragmented, with the company&#8217;s revenue showing some concentration among a handful of states. As with any SME stock, post-listing liquidity may also be limited.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_are_the_lead_manager_and_registrar_for_the_Himalaya_Nutravedics_India_IPO\"><\/span><strong>Who are the lead manager and registrar for the Himalaya Nutravedics India IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nirbhay Capital Services Pvt. Ltd. is the book-running lead manager for the Himalaya Nutravedics India IPO, responsible for structuring and managing the offer process. Kfin Technologies Ltd. is the registrar to the issue and will handle the allotment process and crediting of shares to successful applicants&#8217; demat accounts.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_the_Himalaya_Nutravedics_India_IPO_a_good_investment\"><\/span><strong>Is the Himalaya Nutravedics India IPO a good investment?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Himalaya Nutravedics India offers exposure to a fast-growing Ayurvedic and nutraceutical manufacturer with a diversified business model and strong recent earnings growth, which may interest investors comfortable with SME-scale pharmaceutical and wellness opportunities. However, with the official price band not yet available, a full valuation assessment is not yet possible, and the sustainability of very rapid recent growth is worth watching closely. As always, investors should wait for the official RHP and assess their own risk appetite before applying.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are the Himalaya Nutravedics India IPO dates, and when will it list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Himalaya Nutravedics India IPO opens for subscription on 22 September 2026 and closes on 24 September 2026. The shares are proposed to list on the SME platform of BSE, with the exact listing date to be confirmed closer to the allotment finalisation, as it has not been officially announced at the time of writing.\"}},{\"@type\":\"Question\",\"name\":\"What is the price band for the Himalaya Nutravedics India IPO?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the time of writing, the official price band and lot size for the Himalaya Nutravedics India IPO had not yet been announced. Investors should check the company's official announcements or the RHP closer to the issue opening date on 22 September 2026 for the confirmed price band and minimum investment amount.\"}},{\"@type\":\"Question\",\"name\":\"What does Himalaya Nutravedics India Limited actually manufacture?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Himalaya Nutravedics India manufactures, markets and distributes Ayurvedic and nutraceutical formulations, including classical Shastric Ayurvedic formulations, proprietary Ayurvedic products and nutraceuticals across dosage forms such as soft gelatin capsules, tablets, liquid orals, medicated oils and protein powders. The company targets therapeutic categories including digestive health, immunity, metabolic health and pain management, and also undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies.\"}},{\"@type\":\"Question\",\"name\":\"Is the Himalaya Nutravedics India IPO a fresh issue or does it include an offer for sale?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Himalaya Nutravedics India IPO consists solely of a fresh issue of up to 25,00,000 equity shares, with no offer for sale component. This means, subject to issue expenses, all proceeds raised will flow into the company rather than providing an exit for existing shareholders.\"}},{\"@type\":\"Question\",\"name\":\"How has Himalaya Nutravedics India performed financially in recent years?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Himalaya Nutravedics India's total income grew from Rs 14.43 crore in FY24 to Rs 20.997 crore in FY25 and then to Rs 43.12 crore in FY26, a roughly 105 percent increase in the most recent year. Profit after tax showed an even sharper rise, from Rs 0.43 crore in FY24 to Rs 2.23 crore in FY25 and then to Rs 7.39 crore in FY26, a 231 percent jump, with EBITDA margin improving from around 6.5 percent in FY24 to close to 18.8 percent in FY26.\"}},{\"@type\":\"Question\",\"name\":\"What are the key strengths highlighted for the Himalaya Nutravedics India IPO?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Himalaya Nutravedics India combines a branded Ayurvedic and nutraceutical products business with third-party contract manufacturing, providing revenue diversification across two related business lines. The company has delivered very strong recent growth, with profit after tax rising more than 17 times between FY24 and FY26, supported by multiple quality certifications, including ISO 22000:2018, ISO 9001:2015 and WHO-GMP, and a distribution presence across 17 states and one union territory.\"}},{\"@type\":\"Question\",\"name\":\"What are the main risks or concerns flagged for the Himalaya Nutravedics India IPO?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The most immediate practical concern is that the official price band and lot size were not available at the time of writing, making it difficult for prospective investors to assess valuation until this is confirmed. The company's very rapid recent growth, with profit after tax up 231 percent in FY26, may not be sustainable at the same pace going forward, and the Ayurvedic and nutraceutical industry remains competitive and fragmented, with the company's revenue showing some concentration among a handful of states. As with any SME stock, post-listing liquidity may also be limited.\"}},{\"@type\":\"Question\",\"name\":\"Who are the lead manager and registrar for the Himalaya Nutravedics India IPO?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nirbhay Capital Services Pvt. Ltd. is the book-running lead manager for the Himalaya Nutravedics India IPO, responsible for structuring and managing the offer process. Kfin Technologies Ltd. is the registrar to the issue and will handle the allotment process and crediting of shares to successful applicants' demat accounts.\"}},{\"@type\":\"Question\",\"name\":\"Is the Himalaya Nutravedics India IPO a good investment?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Himalaya Nutravedics India offers exposure to a fast-growing Ayurvedic and nutraceutical manufacturer with a diversified business model and strong recent earnings growth, which may interest investors comfortable with SME-scale pharmaceutical and wellness opportunities. However, with the official price band not yet available, a full valuation assessment is not yet possible, and the sustainability of very rapid recent growth is worth watching closely. As always, investors should wait for the official RHP and assess their own risk appetite before applying.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Himalaya Nutravedics India IPO is a bookbuilding SME issue of up to 25,00,000 equity shares, open for bidding from 22 to 24 September 2026. The Hyderabad based Ayurvedic and nutraceutical manufacturer is raising the entire issue as a fresh issue, with no offer for sale. Share<\/p>\n","protected":false},"author":29,"featured_media":248192,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[],"class_list":["post-248194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["248192"],"rank_math_title":["Himalaya Nutravedics IPO 2026: Review and Details"],"rank_math_description":["Himalaya Nutravedics India IPO opens 22 to 24 September 2026 on BSE SME. Read the full review covering company overview, industry context and financials."],"rank_math_focus_keyword":["Himalaya Nutravedics India IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/himalaya-nutravedics-india-initial-public-offering-review.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/248194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=248194"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/248194\/revisions"}],"predecessor-version":[{"id":248195,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/248194\/revisions\/248195"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/248192"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=248194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=248194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=248194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}